Literature DB >> 11260299

Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation.

A G Nicholson1, L J Perry, P M Cury, P Jackson, C M McCormick, B Corrin, A U Wells.   

Abstract

AIMS: Although many workers have graded pre-invasive squamous lesions arising in the bronchus, there has been no consensus classification system until the latest edition of the WHO/IASLC histological classification of pulmonary and pleural tumours. Because the value of any such system is dependent on its reproducibility, we have circulated a series of such lesions to a panel of histopathologists to assess interobserver and intra-observer variation when the WHO/IASLC classification was applied. METHODS AND
RESULTS: Colour transparencies of 28 pre-invasive squamous lesions were assessed by six histopathologists (two with a special interest in pulmonary pathology, two generalists and two trainees) on three separate occasions over a period of 3 months, using the criteria of the WHO/IASLC (mild, moderate and severe dysplasia, and in-situ carcinoma). An additional category of metaplasia was added for those cases that showed no dysplasia. Weighted kappa coefficents of agreement (K(w)) were used to evaluate paired observations with a standard quadratic weighting being employed, such that kappa coefficients corresponded to intra-class correlation coefficients. Wilcoxon's sign-ranked test was used to measure the statistical significance of group trends, when comparing kappa values for the three grading systems. Various 3-point systems were also assessed, through combination of the above groups. Intra-observer agreement was substantially better than interobserver variation (mean: 0.71 vs. 0.55). Between the various pathologist groups, inter-observer variation was relatively minor, although intra-observer variation was higher within the trainee pathologist group. Using weighted kappa values, there was no significant difference in either inter-observer or intra-observer agreement between the five point grading system and a 3-point system of metaplasia/mild, moderate and severe/in-situ grades. However, there was a significant increase in variation when a 3-point system of metaplasia/mild, moderate/severe and in-situ carcinoma was used.
CONCLUSION: This study shows levels of interobserver and intra-observer variation similar to those found in other grading systems in histopathology, with no significant decrease in variability found by abridging the system. The WHO/IASLC system is therefore recommended for future use in both clinical and research fields.

Entities:  

Mesh:

Year:  2001        PMID: 11260299     DOI: 10.1046/j.1365-2559.2001.01078.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  26 in total

1.  Altered histology provides a positive clinical signal in the bronchial epithelium.

Authors:  Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  Oral iloprost improves endobronchial dysplasia in former smokers.

Authors:  Robert L Keith; Patrick J Blatchford; John Kittelson; John D Minna; Karen Kelly; Pierre P Massion; Wilbur A Franklin; Jenny Mao; David O Wilson; Daniel T Merrick; Fred R Hirsch; Timothy C Kennedy; Paul A Bunn; Mark W Geraci; York E Miller
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

3.  Bimodality surveillance of high-risk patients for lung cancer.

Authors:  Gordon H Downie
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

4.  Lung cancer diagnosis from proteomic analysis of preinvasive lesions.

Authors:  S M Jamshedur Rahman; Adriana L Gonzalez; Ming Li; Erin H Seeley; Lisa J Zimmerman; Xueqiong J Zhang; M Lisa Manier; Sandra J Olson; Ronak N Shah; Alison N Miller; Joe B Putnam; York E Miller; Wilbur A Franklin; William J Blot; David P Carbone; Yu Shyr; Richard M Caprioli; Pierre P Massion
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

Review 5.  [Preneoplastic lesions of pulmonary carcinoma].

Authors:  L Bubendorf
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

6.  Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer.

Authors:  Nagi B Kumar; Gwendolyn P Quinn; Mark G Alexandrow; Jhanelle Gray; Michael Schell; Steve Sutton; Eric B Haura
Journal:  J Clin Trials       Date:  2014-09

7.  Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial.

Authors:  K Häussinger; H Becker; F Stanzel; A Kreuzer; B Schmidt; J Strausz; S Cavaliere; F Herth; M Kohlhäufl; K-M Müller; R-M Huber; U Pichlmeier; Ch T Bolliger
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

8.  Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.

Authors:  Steinn Jonsson; Marileila Varella-Garcia; York E Miller; Holly J Wolf; Tim Byers; Sarah Braudrick; Porntip Kiatsimkul; Marina Lewis; Timothy C Kennedy; Robert L Keith; Johannes Bjornsson; Annette McWilliams; Stephen Lam; Fred R Hirsch; Wilbur A Franklin
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

9.  A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.

Authors:  Karen Kelly; John Kittelson; Wilbur A Franklin; Timothy C Kennedy; Catherine E Klein; Robert L Keith; Edward C Dempsey; Marina Lewis; Mary K Jackson; Fred R Hirsch; Paul A Bunn; York E Miller
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28

Review 10.  Lung cancer chemoprevention: current status and future prospects.

Authors:  Robert L Keith; York E Miller
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.